India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
A new report reveals a sharp 5-fold increase in obesity in India over 30 years, affecting 1 in 4 adults. Learn about the health risks and what it means for the nation.
New Lancet study reveals 25% of Indians face obesity, costing economy ₹29,000 crore annually. Urgent public health action needed to address this growing crisis.
New OSSI survey reveals insurance barriers prevent timely obesity treatment in India. Learn how policy gaps affect patient care and what needs to change.
PGI Chandigarh warns of a sharp increase in Type 2 diabetes among children and young adults, driven by junk food and sedentary lifestyles. Learn how to prevent it.
Lancet study reveals India's ultra-processed food epidemic with retail sales skyrocketing 40-fold since 2006, driving obesity and diabetes crisis among youth. Experts demand urgent policy reforms.
Discover the top 6 lifestyle diseases affecting Indians, their causes, symptoms, and preventive measures. Learn how to protect your health today!
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
Connecting Trust marks 20 years with a 3-day international conference on suicide prevention in Pune. Mental health experts to share insights on building resilience and community support systems. Join the dialogue from November 28-30.
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Assam Police reports significant fitness improvement with only 2.06% of 73,317 personnel classified as obese in annual BMI tests. Discover how the force is getting leaner and mission-ready.
A 16-year-old Mumbai student reversed his Type 2 diabetes risk factors. Discover how an endocrinologist's plan involving diet, exercise, and family support led to a 7 kg weight loss and improved HbA1c levels in six months.
Arjun Kapoor speaks candidly about his mental health journey, starting therapy during lockdown, and overcoming obesity. Read his powerful message on strength.
A 36-year-old Chinese man died days after gastric bypass surgery he hoped would help him impress his girlfriend's parents. The tragedy sparks debate about weight-loss surgery risks.
Lancet study shows child hypertension doubled 2000-2020. 114 million affected globally. Obesity, poor diet, sedentary lifestyles identified as key triggers. Learn prevention strategies.
Novo Nordisk reduces Wegovy price by 37% in India, intensifying the weight loss drug war with Eli Lilly's Mounjaro. Discover the new costs and market impact.
Novo Nordisk reduces its weight loss drug Wegovy's price by 37% in India, intensifying competition with Eli Lilly's Mounjaro. Get the latest details on the new pricing and market dynamics.
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
Groundbreaking research shows even minimal physical activity provides significant cardiovascular protection for both men and women. Discover how small lifestyle changes can yield big health rewards.
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Discover how simple dietary choices can significantly impact your cancer risk. An oncology expert explains which foods to embrace and which to avoid for optimal protection.
Medical experts warn of alarming surge in obesity and heart attacks among young Indians. Discover how adopting Blue Zone lifestyle principles could reverse this dangerous trend.
Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.
New data exposes America's weight divide: Discover which states top the obesity charts and which maintain healthier lifestyles in this comprehensive health analysis.
Former US President Donald Trump is negotiating with Novo Nordisk to offer weight-loss drugs at just $149. Discover how this could revolutionize affordable healthcare and impact India's growing obesity crisis.
As dengue cases surge across India, discover six proven prevention strategies to safeguard your home and loved ones from this dangerous mosquito-borne disease.
Discover how one woman transformed her life by losing 70kg without relying on willpower alone. Her surprising revelation about what really causes weight gain will change everything you thought you knew about dieting.
Breaking news: US FDA approves Rybelsus, the groundbreaking oral weight loss medication that mimics popular injection drugs. Discover how this pill could revolutionise obesity treatment in India and worldwide.
Explore how revolutionary weight-loss medications like Ozempic are transforming lives while raising crucial questions about accessibility, side effects, and long-term sustainability in the Indian context.
Discover the hidden connection between rapid weight fluctuations and kidney damage. Learn about risk factors, prevention tips, and when to seek medical help.